$APYX
Apyx Medical Corp Stock $apyx

$apyx Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000071913520000029 Filed on March 31, 2020

Income Statement

Concept	2020 Q1	2019 Q4	2019 Q3
Revenue	$4.997M	$8.382M	$7.575M
YoY Change	-11.23%	41.44%	106.29%
Cost Of Revenue	$2.013M	$2.380M	$2.281M
YoY Change	-2.57%	3.93%	98.18%
Gross Profit	$2.984M	$5.563M	$5.294M
YoY Change	-16.25%	56.44%	110.0%
Gross Profit Margin	59.72%	66.37%	69.89%
Selling, General & Admin	$3.796M	$10.92M	$3.836M
YoY Change	28.37%	36.84%	102.11%
% of Gross Profit	127.21%	196.3%	72.46%
Research & Development	$980.0K	$1.100M	$1.016M
YoY Change	34.25%	66.67%	65.74%
% of Gross Profit	32.84%	19.77%	19.19%
Depreciation & Amortization	$214.0K	$240.0K	$190.0K
YoY Change	10.31%	0.0%	227.59%
% of Gross Profit	7.17%	4.31%	3.59%
Operating Expenses	$10.48M	$12.02M	$10.05M
YoY Change	12.73%	39.12%	89.3%
Operating Profit	-$7.492M	-$6.457M	-$4.756M
YoY Change	30.75%	27.01%	70.59%
Interest Expense	$6.000K	$230.0K	$0.00
YoY Change		-52.08%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$636.0K	-$360.0K	$557.0K
YoY Change	396.88%	-54.43%	-173.0%
Pretax Income	-$6.856M	-$6.060M	-$4.199M
YoY Change	22.38%	-1.3%	18.25%
Income Tax	-$4.905M	-$250.0K	$171.0K
% Of Pretax Income
Net Earnings	-$1.951M	-$5.810M	-$4.370M
YoY Change	-58.32%	10.67%	-106.38%
Net Earnings / Revenue	-39.04%	-69.32%	-57.69%
Basic Earnings Per Share			-$0.13
Diluted Earnings Per Share	-$57.05K	-$168.1K	-$0.13
COMMON SHARES
Basic Shares Outstanding	34.17M shares	34.17M shares	33.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.40M	$58.80M	$62.30M
YoY Change	-29.88%	-24.9%	-35.17%
Cash & Equivalents	$51.38M	$58.81M	$62.27M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$4.400M	$3.600M	$1.700M
YoY Change	214.29%	9.09%	183.33%
Inventory	$5.872M	$5.068M	$7.237M
Prepaid Expenses
Receivables	$6.122M	$7.987M	$7.662M
Other Receivables	$1.302M	$1.233M	$0.00
Total Short-Term Assets	$74.17M	$76.73M	$78.91M
YoY Change	-13.07%	-14.58%	-26.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.543M	$6.618M	$6.645M
YoY Change	8.78%	14.34%	13.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$482.0K	$391.0K	$387.0K
YoY Change	38.9%	28.2%	0.52%
Total Long-Term Assets	$7.946M	$8.012M	$8.038M
YoY Change	21.5%	31.5%	29.08%
TOTAL ASSETS
Total Short-Term Assets	$74.17M	$76.73M	$78.91M
Total Long-Term Assets	$7.946M	$8.012M	$8.038M
Total Assets	$82.12M	$84.75M	$86.94M
YoY Change	-10.6%	-11.66%	-23.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.535M	$2.438M	$1.457M
YoY Change	68.55%	71.33%	-37.95%
Accrued Expenses	$7.586M	$9.396M	$7.285M
YoY Change	8.23%	30.72%	-63.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$400.0K	$200.0K
YoY Change
Total Short-Term Liabilities	$10.60M	$12.31M	$9.039M
YoY Change	23.04%	42.97%	-59.71%
LONG-TERM LIABILITIES
Long-Term Debt	$400.0K	$400.0K	$600.0K
YoY Change	300.0%
Other Long-Term Liabilities	$520.0K	$114.0K	$600.0K
YoY Change	168.04%
Total Long-Term Liabilities	$520.0K	$114.0K	$1.200M
YoY Change	168.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.60M	$12.31M	$9.039M
Total Long-Term Liabilities	$520.0K	$114.0K	$1.200M
Total Liabilities	$11.69M	$13.49M	$10.21M
YoY Change	29.48%	54.11%	-54.77%
SHAREHOLDERS EQUITY
Retained Earnings	$12.57M	$14.52M	$19.95M
YoY Change	-56.09%	-57.58%	-48.54%
Common Stock	$34.00K	$34.00K	$34.00K
YoY Change	0.0%	0.0%	3.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$70.43M	$71.26M	$76.73M
YoY Change
Total Liabilities & Shareholders Equity	$82.12M	$84.75M	$86.94M
YoY Change	-10.6%	-11.66%	-23.18%

Cashflow Statement

Concept	2020 Q1	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	-$1.951M	-$5.810M	-$4.370M
YoY Change	-58.32%	10.67%	-106.38%
Depreciation, Depletion And Amortization	$214.0K	$240.0K	$190.0K
YoY Change	10.31%	0.0%	227.59%
Cash From Operating Activities	-$7.407M	-$3.260M	-$4.540M
YoY Change	45.55%	-81.93%	291.38%
INVESTING ACTIVITIES
Capital Expenditures	$90.00K	-$220.0K	-$560.0K
YoY Change	-23.08%	37.5%	-530.77%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Cash From Investing Activities	-$90.00K	-$230.0K	-$550.0K
YoY Change	-100.43%	-96.27%	-101.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$15.00K	0.000	30.00K
YoY Change	-77.61%	-100.0%	-101.2%
NET CHANGE
Cash From Operating Activities	-$7.407M	-3.260M	-4.540M
Cash From Investing Activities	-$90.00K	-230.0K	-550.0K
Cash From Financing Activities	$15.00K	0.000	30.00K
Net Change In Cash	-$7.432M	-3.490M	-5.060M
YoY Change	-146.98%	-85.49%	-115.75%
FREE CASH FLOW
Cash From Operating Activities	-$7.407M	-$3.260M	-$4.540M
Capital Expenditures	$90.00K	-$220.0K	-$560.0K
Free Cash Flow	-$7.497M	-$3.040M	-$3.980M
YoY Change	44.01%	-83.0%	208.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	apyx	Conversion Of Series B Convertible Preferred To Common Stock Amount ConversionOfSeriesBConvertiblePreferredToCommonStockAmount	0	USD
CY2019Q4	apyx	Deferred Tax Liabilities Lease Right Of Use Assets DeferredTaxLiabilitiesLeaseRightOfUseAssets	199000	USD
CY2017Q4	apyx	Deferred Tax Liabilities State Taxes Capital DeferredTaxLiabilitiesStateTaxesCapital	17000	USD
CY2018Q4	apyx	Deferred Tax Liabilities State Taxes Capital DeferredTaxLiabilitiesStateTaxesCapital	0	USD
CY2019Q4	apyx	Deferred Tax Liabilities State Taxes Capital DeferredTaxLiabilitiesStateTaxesCapital	0	USD
CY2019	apyx	Defined Contribution Plan Employers Matching Contribution Vesting Percentage After Three Years DefinedContributionPlanEmployersMatchingContributionVestingPercentageAfterThreeYears	1
CY2019	apyx	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P3Y
CY2017	apyx	Discontinued Operations Increase Decrease In Current Assets DiscontinuedOperationsIncreaseDecreaseInCurrentAssets	-362000	USD
CY2018	apyx	Discontinued Operations Increase Decrease In Current Assets DiscontinuedOperationsIncreaseDecreaseInCurrentAssets	2378000	USD
CY2019	apyx	Discontinued Operations Increase Decrease In Current Assets DiscontinuedOperationsIncreaseDecreaseInCurrentAssets	0	USD
CY2017	apyx	Discontinued Operations Increase Decrease In Current Liabilities DiscontinuedOperationsIncreaseDecreaseInCurrentLiabilities	-1451000	USD
CY2018	apyx	Discontinued Operations Increase Decrease In Current Liabilities DiscontinuedOperationsIncreaseDecreaseInCurrentLiabilities	-1021000	USD
CY2019	apyx	Discontinued Operations Increase Decrease In Current Liabilities DiscontinuedOperationsIncreaseDecreaseInCurrentLiabilities	0	USD
CY2017	apyx	Discontinued Operations Increase Decrease In Noncurrent Assets DiscontinuedOperationsIncreaseDecreaseInNoncurrentAssets	632000	USD
CY2018	apyx	Discontinued Operations Increase Decrease In Noncurrent Assets DiscontinuedOperationsIncreaseDecreaseInNoncurrentAssets	1997000	USD
CY2019	apyx	Discontinued Operations Increase Decrease In Noncurrent Assets DiscontinuedOperationsIncreaseDecreaseInNoncurrentAssets	0	USD
CY2018Q3	apyx	Disposal Group Including Discontinued Operation Closing And Transaction Costs DisposalGroupIncludingDiscontinuedOperationClosingAndTransactionCosts	5905000	USD
CY2018Q3	apyx	Disposal Group Including Discontinued Operation Consideration Net Of Closing And Transaction Costs DisposalGroupIncludingDiscontinuedOperationConsiderationNetOfClosingAndTransactionCosts	91095000	USD
CY2018Q3	apyx	Disposal Group Including Discontinued Operation Inventory Non Cash DisposalGroupIncludingDiscontinuedOperationInventoryNonCash	2305000	USD
CY2017	apyx	Effective Income Tax Rate Reconciliation Warrant Gains EffectiveIncomeTaxRateReconciliationWarrantGains	0.004
CY2018	apyx	Effective Income Tax Rate Reconciliation Warrant Gains EffectiveIncomeTaxRateReconciliationWarrantGains	0.000
CY2019	apyx	Effective Income Tax Rate Reconciliation Warrant Gains EffectiveIncomeTaxRateReconciliationWarrantGains	0.000
CY2019	apyx	Finance Lease Payments FinanceLeasePayments	68000	USD
CY2019Q2	apyx	Gross Profit Percentage GrossProfitPercentage	0.703
	apyx	Gross Profit Percentage GrossProfitPercentage	0.671
CY2019Q3	apyx	Gross Profit Percentage GrossProfitPercentage	0.699
	apyx	Gross Profit Percentage GrossProfitPercentage	0.682
CY2017	apyx	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	1375000	USD
CY2018	apyx	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	-194000	USD
CY2019	apyx	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	-4730000	USD
CY2017	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	8620000	USD
CY2018Q3	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	69612000	USD
	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	74134000	USD
CY2018	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	73503000	USD
CY2019	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	0	USD
CY2018Q4	apyx	Joint And Several Payroll Liability JointAndSeveralPayrollLiability	700000	USD
CY2018Q4	apyx	Joint And Several Payroll Liability JointAndSeveralPayrollLiability	713000	USD
CY2019Q4	apyx	Joint And Several Payroll Liability JointAndSeveralPayrollLiability	1000000	USD
CY2019Q4	apyx	Joint And Several Payroll Liability JointAndSeveralPayrollLiability	1045000	USD
CY2018Q4	apyx	Netpropertyplantandequipmentofcontinuinganddiscontinuedoperations Netpropertyplantandequipmentofcontinuinganddiscontinuedoperations	5788000	USD
CY2019Q4	apyx	Netpropertyplantandequipmentofcontinuinganddiscontinuedoperations Netpropertyplantandequipmentofcontinuinganddiscontinuedoperations	6469000	USD
CY2017	apyx	Non Cash Proceeds From Stock Options And Warrants Exercised NonCashProceedsFromStockOptionsAndWarrantsExercised	557000	USD
CY2018	apyx	Non Cash Proceeds From Stock Options And Warrants Exercised NonCashProceedsFromStockOptionsAndWarrantsExercised	3237000	USD
CY2019	apyx	Non Cash Proceeds From Stock Options And Warrants Exercised NonCashProceedsFromStockOptionsAndWarrantsExercised	612000	USD
CY2017	apyx	Non Cash Transfer Of Other Assets To Fixed Assets NonCashTransferOfOtherAssetsToFixedAssets	0	USD
CY2018	apyx	Non Cash Transfer Of Other Assets To Fixed Assets NonCashTransferOfOtherAssetsToFixedAssets	0	USD
CY2019	apyx	Non Cash Transfer Of Other Assets To Fixed Assets NonCashTransferOfOtherAssetsToFixedAssets	42000	USD
CY2017	apyx	Non Cash Transfers Of Inventory To Fixed Assets NonCashTransfersOfInventoryToFixedAssets	0	USD
CY2018	apyx	Non Cash Transfers Of Inventory To Fixed Assets NonCashTransfersOfInventoryToFixedAssets	0	USD
CY2019	apyx	Non Cash Transfers Of Inventory To Fixed Assets NonCashTransfersOfInventoryToFixedAssets	277000	USD
CY2019	apyx	Notes Payable Related Parties Term NotesPayableRelatedPartiesTerm	P5Y
CY2018	apyx	Numberof Employees Sharebased Compensation Arrangementby Sharebased Payment Award Options Modified Vesting Terms NumberofEmployeesSharebasedCompensationArrangementbySharebasedPaymentAwardOptionsModifiedVestingTerms	2	employee
CY2018Q4	apyx	Other Accrued Expenses And Liabilities Current OtherAccruedExpensesAndLiabilitiesCurrent	1367000	USD
CY2019	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	207000	USD
CY2019	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	132000	USD
CY2018Q4	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	439000	USD
CY2019Q4	apyx	Other Accrued Expenses And Liabilities Current OtherAccruedExpensesAndLiabilitiesCurrent	862000	USD
CY2017	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	0	USD
CY2018	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	202000	USD
CY2017	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	0	USD
CY2018	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	0	USD
CY2019Q4	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	392000	USD
CY2017	apyx	Repaymentof Finance Lease Liabilities RepaymentofFinanceLeaseLiabilities	0	USD
CY2018	apyx	Repaymentof Finance Lease Liabilities RepaymentofFinanceLeaseLiabilities	0	USD
CY2019	apyx	Repaymentof Finance Lease Liabilities RepaymentofFinanceLeaseLiabilities	60000	USD
CY2019	apyx	Sales Discount Billing Terms Lower Limit SalesDiscountBillingTermsLowerLimit	P10D
CY2019	apyx	Sales Discount Billing Terms Upper Limit SalesDiscountBillingTermsUpperLimit	P90D
CY2017	apyx	Share Based Compensation Arrangement By Share Based Payment Award Options Surrendered In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSurrenderedInPeriod	34687	shares
CY2018	apyx	Share Based Compensation Arrangement By Share Based Payment Award Options Surrendered In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSurrenderedInPeriod	22711	shares
CY2017	apyx	Share Based Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	3140000	USD
CY2018	apyx	Share Based Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	540000	USD
CY2019	apyx	Share Based Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	6300000	USD
CY2019Q4	apyx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Intrinsic Value Closing Stock Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIntrinsicValueClosingStockPrice	8.46
CY2017	apyx	Stock Issued During Period Shares Stock Swaps StockIssuedDuringPeriodSharesStockSwaps	47372	shares
CY2018	apyx	Stock Issued During Period Shares Stock Swaps StockIssuedDuringPeriodSharesStockSwaps	720772	shares
CY2019	apyx	Stock Issued During Period Shares Stock Swaps StockIssuedDuringPeriodSharesStockSwaps	222601	shares
CY2018	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	0	USD
CY2017	apyx	Stock Swap To Acquire Options Shares StockSwapToAcquireOptionsShares	19688	shares
CY2018	apyx	Stock Swap To Acquire Options Shares StockSwapToAcquireOptionsShares	17289	shares
CY2017	apyx	Total Revenue Percent TotalRevenuePercent	0.132
CY2018	apyx	Total Revenue Percent TotalRevenuePercent	0.226
CY2019	apyx	Total Revenue Percent TotalRevenuePercent	0.306
CY2018Q4	apyx	Uncertain Tax Positions Liability UncertainTaxPositionsLiability	1325000	USD
CY2019Q4	apyx	Uncertain Tax Positions Liability UncertainTaxPositionsLiability	1491000	USD
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0000719135
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34174314	shares
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Accelerated Filer
CY2019Q2	dei	Entity Public Float EntityPublicFloat	226500000	USD
CY2019	dei	Entity Registrant Name EntityRegistrantName	APYX MEDICAL CORP
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2348000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1423000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1504000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2438000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4139000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3721000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4044000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5292000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7987000	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	972000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1306000	USD
CY2018Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	725000	USD
CY2019Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1170000	USD
CY2019Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7230000	USD
CY2019Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	8366000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20088000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7188000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7009000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9396000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	331000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1383000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	418000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	694000	USD
CY2018Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	379000	USD
CY2019Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	877000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6358000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4403000	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51798000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52920000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54182000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56708000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	871000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2224000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3581000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	1100000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	800000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	1500000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	871000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2224000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3581000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	400000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	428000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	300000	USD
CY2018Q3	us-gaap	Assets Assets	113173000	USD
CY2018Q4	us-gaap	Assets Assets	95928000	USD
CY2019Q1	us-gaap	Assets Assets	91856000	USD
CY2019Q4	us-gaap	Assets Assets	84745000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	273000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	106946000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	89835000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	85316000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	76733000	USD
CY2018Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	4249000	USD
CY2018Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2252000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	247000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	78027000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	78274000	USD
CY2018Q4	us-gaap	Cash Cash	6467000	USD
CY2019Q4	us-gaap	Cash Cash	2237000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40663000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16596000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32415000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58812000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15235000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10668000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16596000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58812000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4567000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5928000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	42216000	USD
CY2017	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	7428000	USD
CY2018	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	68233000	USD
CY2019	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33763019	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33847100	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34033255	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34312527	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33620444	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33704525	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33891255	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34169952	shares
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	33000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	100000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	400000	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3276000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1151000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1975000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2066000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3490000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5779000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4041000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2281000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6322000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9141000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-3073000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-12000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	17000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	20000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	87000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	39000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-3937000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-130000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	22000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-884000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-205000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1581000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-171000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3989000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1180000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-164000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4730000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	555000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	150000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	444000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-401000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	7000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-741000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	146000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	34000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8943000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1892000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6916000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	494000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	115000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	99000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	187000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	150000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	444000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	178000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	910000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	549000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	721000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1004000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8756000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	244000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1742000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6472000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	368000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	294000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	150000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	245000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.03
CY2019	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.5
CY2017	us-gaap	Depreciation Depreciation	600000	USD
CY2018	us-gaap	Depreciation Depreciation	400000	USD
CY2019	us-gaap	Depreciation Depreciation	700000	USD
CY2017	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	529000	USD
CY2018	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	126000	USD
CY2019	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	0	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	696000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	669000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	754000	USD
CY2017	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-183000	USD
CY2018	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2019	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2018Q3	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	84541000	USD
CY2018Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	68404000	USD
CY2017	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0	USD
CY2018Q3	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	69072000	USD
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	69072000	USD
CY2018	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	68404000	USD
CY2019	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	0	USD
CY2017	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.27
CY2018Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	2.09
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	2.25
CY2018	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	2.21
CY2019	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.00
CY2017	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.27
CY2018Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	1.99
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	2.19
CY2018	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	2.14
CY2019	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.00
CY2018	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1200000	USD
CY2018Q3	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	2195000	USD
CY2018Q3	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	57000	USD
CY2018Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	16137000	USD
CY2018Q3	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	1997000	USD
CY2018Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	0	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	149000	USD
CY2018Q3	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	375000	USD
CY2018Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	140000	USD
CY2018Q3	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	140000	USD
CY2018Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	140000	USD
CY2019Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	140000	USD
CY2019Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.04
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.96
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.98
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.289
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.013
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.238
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.712
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.031
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.266
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.007
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.062
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.013
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.048
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.056
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.043
CY2018	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	190000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3520000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	8000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	650000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	229000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	421000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	688000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	251000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	18000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	183000	USD
CY2019Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	236000	USD
CY2019Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	38000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	653000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	57000	USD
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0400
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M5D
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-89000	USD
CY2017	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	247000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	164000	USD
CY2017	us-gaap	Gross Profit GrossProfit	6958000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	2212000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	2537000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	2521000	USD
	us-gaap	Gross Profit GrossProfit	7270000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	3556000	USD
CY2018	us-gaap	Gross Profit GrossProfit	10826000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	3563000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	4674000	USD
	us-gaap	Gross Profit GrossProfit	8237000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	5294000	USD
	us-gaap	Gross Profit GrossProfit	13531000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	5563000	USD
CY2019	us-gaap	Gross Profit GrossProfit	19094000	USD
CY2017	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13682000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2791000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2938000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1143000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6872000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3912000	USD
CY2018	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10784000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5608000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4370000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5433000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4295000	USD
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19706000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13838000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3551000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9256000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14691000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5602000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19836000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.44
CY2018Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.03
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.21
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.32
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.58
CY2018Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2018Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2018Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2019Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2019Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.16
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8620000	USD
CY2018Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	540000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5062000	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5099000	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-156000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2408000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2384000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3907000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-130000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	32000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	13283000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	325000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-23000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-224000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1054000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	303000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	447000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3970000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	710000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15341000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2370000	USD
CY2017	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	196000	USD
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	368000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	USD
CY2017	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-183000	USD
CY2018	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-20000	USD
CY2019	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	368000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1185000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2367000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	30000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2851000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	406000	USD
CY2017	us-gaap	Interest Expense InterestExpense	136000	USD
CY2018	us-gaap	Interest Expense InterestExpense	104000	USD
CY2019	us-gaap	Interest Expense InterestExpense	8000	USD
CY2018Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	105000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	33000	USD
CY2017	us-gaap	Interest Income Operating InterestIncomeOperating	0	USD
CY2018	us-gaap	Interest Income Operating InterestIncomeOperating	616000	USD
CY2019Q1	us-gaap	Interest Income Operating InterestIncomeOperating	423000	USD
CY2019	us-gaap	Interest Income Operating InterestIncomeOperating	1392000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	136000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	104000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	8000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	585000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1316000	USD
CY2018Q4	us-gaap	Inventory Gross InventoryGross	3585000	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	5460000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	6037000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	3146000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	3013000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	5068000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2594000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2935000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	439000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	392000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	406000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1209000	USD
CY2019	us-gaap	Lease Cost LeaseCost	196000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0400
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	365000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	221000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	120000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	121000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	124000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	22576000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	8751000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	9025000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	13486000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	113173000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95928000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	91856000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84745000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	22436000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8611000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8616000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12311000	USD
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	56575000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-239000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2492000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	147000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-624000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29301000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	60541000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3704000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20881000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18475000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-5062000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	68469000	USD
	us-gaap	Net Income Loss NetIncomeLoss	67262000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	62719000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-19706000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5062000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	62719000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19706000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5245000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	62719000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-19706000	USD
CY2019Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	100000	USD
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2017	us-gaap	Operating Expenses OperatingExpenses	20843000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	5309000	USD
	us-gaap	Operating Expenses OperatingExpenses	15711000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	25102000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	9293000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	39963000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-13885000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2788000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8441000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-14276000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5730000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-20869000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	115000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	343000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	103000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	108000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	75000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	235000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	106000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	178000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	350000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M23D
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	385000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	305000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	347000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	391000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	194000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	519000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-763000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-815000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-415000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	128000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1033000	USD
CY2017	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2018Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-868000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-868000	USD
CY2018	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-947000	USD
CY2019Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-295000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-495000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-265000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-351000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1359000	USD
CY2019Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	925000	USD
CY2019Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1233000	USD
CY2017	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	87189000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18884000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	624000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	363000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1301000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	627000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3335000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4034000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3633000	USD
CY2018Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	97000000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3700000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	38766000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34223000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	28615000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	24320000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	19950000	USD
CY2018Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	97000000	USD
CY2017	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2018	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	91095000	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	25758000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	80726000	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	348000	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	452000	USD
CY2017	us-gaap	Product Warranty Expense ProductWarrantyExpense	0	USD
CY2018	us-gaap	Product Warranty Expense ProductWarrantyExpense	0	USD
CY2019	us-gaap	Product Warranty Expense ProductWarrantyExpense	321000	USD
CY2017	us-gaap	Professional Fees ProfessionalFees	1769000	USD
CY2018Q3	us-gaap	Professional Fees ProfessionalFees	628000	USD
	us-gaap	Professional Fees ProfessionalFees	1815000	USD
CY2018	us-gaap	Professional Fees ProfessionalFees	3133000	USD
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	2118000	USD
CY2019Q2	us-gaap	Professional Fees ProfessionalFees	1661000	USD
	us-gaap	Professional Fees ProfessionalFees	3779000	USD
CY2019Q3	us-gaap	Professional Fees ProfessionalFees	2039000	USD
	us-gaap	Professional Fees ProfessionalFees	5818000	USD
CY2019	us-gaap	Professional Fees ProfessionalFees	8507000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12146000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10872000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5842000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5788000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6015000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6618000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	179000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	224000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-163000	USD
CY2019Q4	us-gaap	Purchase Obligation PurchaseObligation	2000000	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	239000	USD
CY2018	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2694000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1941000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1900000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	613000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1890000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2549000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2500000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	730000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1618000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1016000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2634000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3731000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14517000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10234000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3397000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3691000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3672000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10760000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5845000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16605000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5629000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6649000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12278000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7575000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19853000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8382000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28235000	USD
CY2017	us-gaap	Salaries And Wages SalariesAndWages	6920000	USD
CY2018Q3	us-gaap	Salaries And Wages SalariesAndWages	2170000	USD
	us-gaap	Salaries And Wages SalariesAndWages	5785000	USD
CY2018	us-gaap	Salaries And Wages SalariesAndWages	9272000	USD
CY2019Q1	us-gaap	Salaries And Wages SalariesAndWages	3488000	USD
CY2019Q2	us-gaap	Salaries And Wages SalariesAndWages	3510000	USD
	us-gaap	Salaries And Wages SalariesAndWages	6998000	USD
CY2019Q3	us-gaap	Salaries And Wages SalariesAndWages	3159000	USD
	us-gaap	Salaries And Wages SalariesAndWages	10157000	USD
CY2019	us-gaap	Salaries And Wages SalariesAndWages	14025000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8689000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1898000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6221000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9407000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2957000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3037000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5994000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3836000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9830000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13700000	USD
CY2017	us-gaap	Severance Costs1 SeveranceCosts1	1524000	USD
CY2018Q4	us-gaap	Severance Costs1 SeveranceCosts1	700000	USD
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	741000	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	0	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	871000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	2224000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3581000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P7Y
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.680
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.688
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.664
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.621
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.609
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4460000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1420000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	443302	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	225841	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	256785	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.649
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	220000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.95
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.10
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.76
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1728000	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	225000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1379500	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.82
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.40
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.57
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3526287	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4634235	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3254779	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3966858	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.17
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.10
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.18
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.67
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2481929	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.33
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	14820000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3772139	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.53
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.41
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.43
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.99
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.09
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.40
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.70
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	12730000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1436429	shares
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1484929	shares
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	212000	shares
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.31
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.68
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.11
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	810000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	61678000	USD
CY2019Q1	us-gaap	Short Term Investments ShortTermInvestments	40885000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2017Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	233000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1440000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2130000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1119000	shares
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	348000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.90
CY2018Q3	us-gaap	Short Term Investments ShortTermInvestments	55480000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	452000	USD
CY2018	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	138000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	217000	USD
CY2018	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	253000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	321000	USD
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	176750	shares
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1378615	shares
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	410635	shares
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	202000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	207000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	26223000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	22032000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	90597000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	87177000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	82831000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	71259000	USD
CY2018Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	610000	USD
CY2019Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	116000	USD
CY2017Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	7722000	USD
CY2018Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	0	USD
CY2019Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	4779000	USD
CY2017	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	183000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	20000	USD
CY2018	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	20000	USD
CY2019	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1300000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1300000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	200000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	200000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	16000	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31427000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34934000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33952000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34366000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34069000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33343000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	31420000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	33185000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	34069000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31420000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33275000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33014000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33185000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34069000	shares
CY2019	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases </font><font style="font-family:inherit;font-size:10pt;">(Topic 842). Topic 842 establishes a new lease model, referred to as the right-of-use model that brings substantially all leases on the balance sheet. This standard requires lessees to recognize leased assets and lease liabilities on the balance sheet and disclose key information about the leasing arrangements in their financial statements. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted Topic 842 effective January 1, 2019 using the modified retrospective transition approach that allows a reporting entity to use the effective date as its date of initial application and not restate the comparative periods in the period of adoption when transitioning to the new standard. Consequently, the requisite financial information and disclosures under the new standard are excluded for dates and periods prior to January 1, 2019. In addition, the Company elected to use a number of optional simplification and practical expedients permitted under the transition guidance within the new standard, including allowing the Company to combine fixed lease and non-lease components, apply the short-term lease exception to all leases of one year or less, and utilize the ‘package of practical expedients’, which permits the Company to not reassess prior accounting conclusions with respect to lease identification, lease classification and initial direct costs under Topic 842. Adoption of this new standard resulted in the recognition of approximately </font><font style="font-family:inherit;font-size:10pt;">$212,000</font><font style="font-family:inherit;font-size:10pt;"> of operating lease liabilities and right-of-user assets, which represents the present value of the remaining lease payments at the adoption date of approximately </font><font style="font-family:inherit;font-size:10pt;">$221,000</font><font style="font-family:inherit;font-size:10pt;">, discounted using the Company’s incremental borrowing rate of </font><font style="font-family:inherit;font-size:10pt;">4.00%</font><font style="font-family:inherit;font-size:10pt;">. Please see Note 9 for a full discussion of the impacts of adoption on the current year consolidated financial statements. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on our consolidated financial statements or disclosures.</font></div></div>
CY2019	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have reclassified certain amounts presented in prior years to conform to the current year presentation. These reclassifications had no impact on previously reported net income, retained earnings or operating cash flows for the periods presented. </font></div></div>
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates in the Preparation of Financial Statements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. The reported amounts of revenues and expenses during the reporting period may be affected by the estimates and assumptions we are required to make.</font></div></div>

Files In Submission

Name	View Source	Status
0000719135-20-000029-index-headers.html	Edgar Link	pending
0000719135-20-000029-index.html	Edgar Link	pending
0000719135-20-000029.txt	Edgar Link	pending
0000719135-20-000029-xbrl.zip	Edgar Link	pending
a2019q410-k.htm	Edgar Link	pending
a2019q410-kexhibit211.htm	Edgar Link	pending
a2019q410-kexhibit311.htm	Edgar Link	pending
a2019q410-kexhibit312.htm	Edgar Link	pending
a2019q410-kexhibit321.htm	Edgar Link	pending
a2019q410-kexhibit322.htm	Edgar Link	pending
apyx-20191231.xml	Edgar Link	completed
apyx-20191231.xsd	Edgar Link	pending
apyx-20191231_cal.xml	Edgar Link	unprocessable
apyx-20191231_def.xml	Edgar Link	unprocessable
apyx-20191231_lab.xml	Edgar Link	unprocessable
apyx-20191231_pre.xml	Edgar Link	unprocessable
apyxdescriptionofsecurit.htm	Edgar Link	pending
apyxdescriptionofsecurit001.jpg	Edgar Link	pending
apyxmedicalcodeofbusines.htm	Edgar Link	pending
apyxmedicalcodeofbusines001.jpg	Edgar Link	pending
apyxmedicalcodeofbusines002.jpg	Edgar Link	pending
apyxmedicalcodeofbusines003.jpg	Edgar Link	pending
apyxmedicalcodeofbusines004.jpg	Edgar Link	pending
apyxmedicalcodeofbusines005.jpg	Edgar Link	pending
apyxmedicalcodeofbusines006.jpg	Edgar Link	pending
apyxmedicalcodeofbusines007.jpg	Edgar Link	pending
apyxmedicalcodeofbusines008.jpg	Edgar Link	pending
apyxmedicalcodeofbusines009.jpg	Edgar Link	pending
apyxmedicalcodeofbusines010.jpg	Edgar Link	pending
apyxmedicalcodeofbusines011.jpg	Edgar Link	pending
apyxmedicalcodeofbusines012.jpg	Edgar Link	pending
apyxmedicalcodeofbusines013.jpg	Edgar Link	pending
apyxmedicallogotagline.jpg	Edgar Link	pending
chart-e6732290a2e25e189a9.jpg	Edgar Link	pending
exhibit231bdoconsent.htm	Edgar Link	pending
exhibit231bdoconsent001.jpg	Edgar Link	pending
exhibit232fdconsent.htm	Edgar Link	pending
exhibit232fdconsent001.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APYX
Apyx Medical Corp Stock $apyx

2020 Q1 Form 10-K Financial Statement

#000071913520000029 Filed on March 31, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX Apyx Medical Corp Stock $apyx

2020 Q1 Form 10-K Financial Statement

#000071913520000029 Filed on March 31, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX
Apyx Medical Corp Stock $apyx